Genetic variants in the vitamin D receptor gene and prostate cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 4, 2005, Pages 997-999

  Hayes, Vanessa M ^a   Severi, Gianluca ^b   Padilla, Emma J D ^a   Eggleton, Sarah A ^a   Southey, Melissa C ^c   Sutherland, Robert L ^a   Hopper, John L ^c   Giles, Graham G ^b  

^a ST VINCENT S HOSPITAL   (Australia)

^b CANCER EPIDEMIOLOGY CENTRE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D RECEPTOR;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; AGE DISTRIBUTION; ARTICLE; AUSTRALIA; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; RECEPTOR GENE; RISK ASSESSMENT;

ADULT; AUSTRALIA; CASE-CONTROL STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RECEPTORS, CALCITRIOL; RISK;

EID: 16444371566     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-04-0660     Document Type: Article

References (15)

1. 3 on primary cultures of human prostatic cells. Cancer Res 1994;54:805-10.
2. Walters MR. Newly identified actions of the vitamin D endocrine system. Endocrinol Rev 1992;13:1-46.
3. Zmuda JM, Cauley JA, Ferrell RE. Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev 2000;22:203-17.
4. Whitfield GK, Remus LS, Jurutka PW, et al. Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol 2001;177:145-59.
5. Severi G, Giles GG, Southey MC, et al. No association between ELAC2/HPC2 polymorphisms and serum prostate-specific antigen level or prostate cancer. J Natl Cancer Inst 2003;95:818-24.
6. Ingles SA, Haile RW, Henderson BE, et al. Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: implications for association studies. Cancer Epidemiol Biomarkers Prev 1997;6:93-8.
7. Correa-Cerro L, Berthon P, Haussler J, et al. Vitamin D receptor polymorphisms as markers in prostate cancer. Hum Genet 1999;105:281-7.
8. Ma J, Stampfer MJ, Gann PH, et al. Vitamin D receptor polymorphisms, circulating metabolites, and risk of prostate cancer in United States physicians. Cancer Epidemiol Biomarkers Prev 1998;7:385-90.
9. Luscombe CJ, French ME, Liu S, et al. Outcome in prostate cancer associations with skin type and polymorphism in pigmentation-related genes. Carcinogenesis 2001;22:1343-7.
10. Xu Y, Shibata A, McNeal JE, Stamey TA, Feldman D, Peehl DM. Vitamin D receptor start codon polymorphism (FokI) and prostate cancer progression. Cancer Epidemiol Biomarkers Prev 2003;12:23-7.
11. Ntais C, Polycarpou A, Ioannidis JPA. Vitamin D receptor gene polymorphisms and risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2003;12:1395-402.
12. Keitheri Cheteri MB, Stanford JL, Friedrichsen DM, et al. Vitamin D receptor gene polymorphisms and prostate cancer risk. Prostate 2004;59:409-18.
13. Studzinski GP, Moore DC. Sunlight - can it prevent as well as cause cancer? Cancer Res 1996;56:4108-10.
14. Ingles SA, Ross RK, Yu MC, et al. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 1997;89:166-70.
15. Bodiwala D, Luscombe CJ, French ME, et al. Polymorphisms in the vitamin D receptor gene, ultraviolet radiation, and susceptibility to prostate cancer. Environ Mol Mutagen 2004;43:121-7.